NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Serena Santangelo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Via Fratelli Cervi 93, Segrate, Milan 20054, Italy. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, NIMA-Related Kinase 1, DNA Damage, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BIBLIOSAN, Italian Ministery of Health.
Abstract (Originalsprache)
The hexanucleotide G4C2 repeat expansion (HRE) in C9ORF72 gene is the major cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), leading to both loss- and gain-of-function pathomechanisms. The wide clinical heterogeneity among C9ORF72 patients suggests potential modifying genetic and epigenetic factors. Notably, C9ORF72 HRE often co-occurs with other rare variants in ALS/FTD-associated genes, such as NEK1, which encodes for a kinase involved in multiple cell pathways, including DNA damage response and ciliogenesis. In this study, we generated induced pluripotent stem cells (iPSCs) and differentiated motoneurons (iPSC-MNs) from an ALS patient carrying both C9ORF72 HRE and a NEK1 loss-of-function mutation to investigate the biological effect of NEK1 haploinsufficiency on C9ORF72 pathology in a condition of oligogenicity. Double mutant C9ORF72/NEK1 cells showed increased pathological C9ORF72 RNA foci in iPSCs and higher DNA damage levels in iPSC-MNs compared to single mutant C9ORF72 cells, but no effect on DNA damage response. When we analysed the primary cilium, we observed a defective ciliogenesis in C9ORF72 iPSC-MNs which was not worsened by NEK1 haploinsufficiency in the double mutant iPSC-MNs. Altogether, our study shows that NEK1 haploinsufficiency influences differently DNA damage and cilia length, potentially acting as a modifier at biological level in an in vitro ALS patient-derived disease model of C9ORF72 pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Via Fratelli Cervi 93, Segrate, Milan 20054, Italy.
- Department of Neuroscience - Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Via Zucchi 18, Cusano Milanino, Milan 20095, Italy.
- Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, Pavia 27100, Italy.
- "Dino Ferrari" Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Via Francesco Sforza 35, Milan 20122, Italy.
ORCID-Profile: Antonia Ratti
Förderung
- BIBLIOSAN
- Italian Ministery of Health
Zitieren
APA
Santangelo, S., Invernizzi, S., Sorce, M. N., Casiraghi, V., Peverelli, S., Brusati, A., Colombrita, C., Ticozzi, N., Silani, V., Bossolasco, P., & Ratti, A. (2024). NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae121
Vancouver
Santangelo S, Invernizzi S, Sorce MN, Casiraghi V, Peverelli S, Brusati A, et al. NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae121
BibTeX
@article{Santangelo2024,
author = {Santangelo, Serena and Invernizzi, Sabrina and Sorce, Marta Nice and Casiraghi, Valeria and Peverelli, Silvia and Brusati, Alberto and Colombrita, Claudia and Ticozzi, Nicola and Silani, Vincenzo and Bossolasco, Patrizia and Ratti, Antonia},
title = {NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae121}
}
EUVIMED